Table 2.
Number and ratio for each reason of donor exclusion during phase I of the living donor evaluation protocol
| Phase | Step | n | Exclusion | n | % from the step |
| Phase I | Confirmation of the relative | 1004 | Non-related donor | 2 | 0.19 |
| Age | 1002 | Over age limit | 223 | 22.25 | |
| BMI | 779 | Overweight | 26 | 3.33 | |
| Underweight | 5 | 0.64 | |||
| Clinical evaluation | 748 | Uncontrolled HTN | 2 | 0.26 | |
| Initial surgical evaluation | 746 | Upper abdominal surgery | 6 | 0.8 | |
| Psychological evaluation | 740 | Algophobia | 1 | 0.13 | |
| Hesitation | 3 | 0.4 | |||
| ABO compatibility | 736 | ABO incompatibility | 102 | 13.85 | |
| 634 | Withdrawal | 23 | 3.62 | ||
| CBC and biochemistry | 611 | thrombocytopenia | 3 | 0.49 | |
| uncontrolled DM | 4 | 0.65 | |||
| elevated liver enzymes | 7 | 1.14 | |||
| hyperbilirubinemia | 2 | 0.32 | |||
| hypoalbuminemia | 1 | 0.16 | |||
| 594 | Family refusal | 5 | 0.84 | ||
| Withdrawal | 6 | 1.01 | |||
| Pregnancy test | 583 | Positive test | 16 | 2.74 | |
| Abdominal US | 567 | Splenomegaly | 1 | 0.17 | |
| Fatty liver | 1 | 0.17 | |||
| 565 | Withdrawal | 29 | 5.13 | ||
| Serological assessment | 536 | HCV positive | 39 | 7.27 | |
| HBV positive | 34 | 6.34 | |||
| CMV positive | 7 | 1.3 | |||
| EBV positive | 1 | 0.18 | |||
| HCV and HBV positive | 6 | 1.11 | |||
| HCV and CMV positive | 1 | 0.18 | |||
| 448 | Withdrawal | 9 | 2.0 | ||
| Anesthetic reassessment | 439 | Smoker | 28 | 6.37 | |
| IHD | 2 | 0.45 | |||
| Rheumatic heart disease | 3 | 0.68 | |||
| Valvular heart disease | 3 | 0.68 | |||
| Atrial ectopics | 1 | 0.22 | |||
| 402 | Withdrawal | 31 | 7.71 |
HCV: Hepatitis C virus; HBV: Hepatitis B virus; CMV: Cytomegalovirus.